Anna Guralnik
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
- IL-33, ST2, and ILC Pathways
- Immunodeficiency and Autoimmune Disorders
- Immune Response and Inflammation
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions
Papers in
-
- T-cell and B-cell Immunology 9
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 5
- Psoriasis: Treatment and Pathogenesis 3
- IL-33, ST2, and ILC Pathways 1
- Genetics 1
- Chronic Lymphocytic Leukemia Research 1
- Co-authors
- Magdalena Huber (9 shared papers)Michael Lohoff (6 shared papers)Anne Brüstle (4 shared papers)Katharina Reinhard (5 shared papers)Azita J. Mahiny (2 shared papers)Hans‐Willi Mittrücker (3 shared papers)Eberhard von Löw (1 shared paper)Gina Walter (1 shared paper)
- Journals
- European Journal of Immunology (3 papers)Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- GermanyCanadaNetherlands
In The Last Decade
Anna Guralnik
9 papers receiving 975 citations
Peers
Comparison fields: 5 of 72
- Immunology 769
- Oncology 210
- Pathology and Forensic Medicine 114
- Dermatology 57
- Neurology 38
Countries citing papers authored by Anna Guralnik
This map shows the geographic impact of Anna Guralnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Guralnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Guralnik more than expected).
Fields of papers citing papers by Anna Guralnik
This network shows the impact of papers produced by Anna Guralnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Guralnik. The network helps show where Anna Guralnik may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Guralnik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 235 | |
| 2 | 2012 | 193 | |
| 3 | 2009 | 187 | |
| 4 | 2007 | 156 | |
| 5 | 2013 | 74 | |
| 6 | 2012 | 60 | |
| 7 | 2012 | 38 | |
| 8 | 2017 | 33 | |
| 9 | 2013 | 9 |
About Anna Guralnik
Anna Guralnik is a scholar working on Immunology, Genetics, Oncology, Infectious Diseases and Organic Chemistry, having authored 9 papers that have together received 985 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers), Psoriasis: Treatment and Pathogenesis (3 papers), IL-33, ST2, and ILC Pathways (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Chronic Lymphocytic Leukemia Research (1 paper). The work is most often cited by research in Immunology (769 citations), Oncology (210 citations), Pathology and Forensic Medicine (114 citations), Dermatology (57 citations) and Neurology (38 citations). Anna Guralnik has collaborated with scholars based in Germany, Canada and Netherlands. Frequent co-authors include Magdalena Huber, Michael Lohoff, Anne Brüstle, Katharina Reinhard, Azita J. Mahiny, Hans‐Willi Mittrücker, Eberhard von Löw, Gina Walter, Sylvia Heink and Thomas Kamradt. Their work appears in journals such as European Journal of Immunology, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation, Nature Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.